Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation Trial of Taxane Therapy and Risk of Neuropathy in African American Women with Breast Cancer
NCT04001829Phase 2Active, not recruiting
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Aug 2019
- Primary completion
- Sep 2023
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, docetaxel in breast cancer, sponsored by ECOG-ACRIN Cancer Research Group. Started Aug 2019; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injectiondocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04001829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04001829.